Rimegepant 75 mg Exposure, Safety, and Tolerability are Similar in Elderly and Nonelderly Adults: a Phase 1, Open-Label, Parallel-Group, Single-Dose Study (2101)

20202 citationsJournal Article

Authors

The objective of this study was to evaluate the pharmacokinetics (PK), safety, and tolerability of rimegepant in elderly and nonelderly adults.

Good health and well-being

Published in: Neurology

Volume 94, Issue 15_supplement

Field-Weighted Citation Impact: 0.24